FDA Advisers Recommend Ferring's Fecal Transplant Therapy
A panel of U.S. Food and Drug Administration advisers voted in favor of Ferring Pharmaceuticals' fecal transplant-based therapy to reduce the recurrence of a bacterial infection, bringing the first therapy of its kind closer to approval. The therapy, Rebyota, works by replenishing the good gut bacteria through samples of microbes distilled from faeces of healthy donors, delivered through an enema in this case. Besides Switzerland-based Ferring, other companies including Seres Therapeutics, which is developing an oral treatment, are working on similar therapies based on fecal microbiota transplantation (FMT).
@rohini Right now, patients can get an FMT from their roommates, or if this get approval, they can get a defined FMT that has undergone some sort of quality control